Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen.

Doctors explain why headaches are popular among Wegovy and Ozempic patients and how to treat and prevent them, including ...

Wegovy and Mounjaro are two prescription drugs available to help with weight loss and management. Find out how they’re alike and different.

A class of drugs that includes popular medications like Ozempic, Wegovy, Rybelsus (semaglutide) or Mounjaro and Zepbound (tirzepatide) has not only proven effective in treating weight loss and ...

Danish drugmaker Novo first-to-market with obesity shot Wegovy U.S. rival Eli Lilly's Mounjaro led to greater weight loss in trials Mounjaro sales outstripping Wegovy in UK, online pharmacies say ...

Finally, in 2023, Simonson's doctor put her on Mounjaro, one of the new class of highly touted diabetes and weight-loss drugs, and the pounds finally came off and stayed off.

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show the medications for Type 2 diabetes and weight loss can decrease the ...

Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But a rise in so-called "Ozempic babies" has led ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.

Mounjaro led to greater average weight loss than Wegovy in a 72-week trial Participants on Mounjaro lost more body weight and had better metabolic outcomes Experts say both drugs are useful but ...